| Net Cash Provided by (Used in) Operating Activities |
$308,058,000 |
USD |
9.2% |
Q4 2025 |
Q1 2026 |
| Net Cash Provided by (Used in) Financing Activities |
$895,293,000 |
USD |
0.88% |
Q4 2025 |
Q1 2026 |
| Net Cash Provided by (Used in) Investing Activities |
$1,035,643,000 |
USD |
-17% |
Q4 2025 |
Q1 2026 |
| Common Stock, Shares Authorized |
200,000,000 |
shares |
0% |
Q4 2025 |
Q1 2026 |
| Common Stock, Shares, Issued |
165,434,477 |
shares |
4.2% |
Q4 2025 |
Q1 2026 |
| Common Stock, Par or Stated Value Per Share |
0.005 |
USD/shares |
0% |
Q4 2025 |
Q1 2026 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$167,708,000 |
USD |
-40% |
Q4 2025 |
Q1 2026 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$371,511,000 |
USD |
-37% |
Q4 2025 |
Q1 2026 |
| Deferred Tax Assets, Valuation Allowance |
$1,365,000 |
USD |
-6.3% |
Q3 2025 |
FY 2025 |
| Deferred Tax Assets, Gross |
$657,549,000 |
USD |
-3.8% |
Q3 2025 |
FY 2025 |
| Operating Lease, Liability |
$307,559,000 |
USD |
19% |
Q3 2025 |
FY 2025 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
$1,237,932,000 |
USD |
13% |
Q4 2025 |
Q1 2026 |
| Lessee, Operating Lease, Liability, to be Paid |
$375,802,000 |
USD |
17% |
Q3 2025 |
FY 2025 |
| Operating Lease, Liability, Current |
$45,010,000 |
USD |
31% |
Q3 2025 |
FY 2025 |
| Operating Lease, Weighted Average Discount Rate, Percent |
0.045 |
pure |
9.8% |
Q3 2025 |
FY 2025 |
| Deferred Income Tax Expense (Benefit) |
$93,044,000 |
USD |
31% |
Q4 2025 |
Q1 2026 |
| Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
$68,243,000 |
USD |
11% |
Q3 2025 |
FY 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$473,642,000 |
USD |
-2.3% |
Q3 2025 |
FY 2025 |
| Unrecognized Tax Benefits |
$60,332,000 |
USD |
4.4% |
Q3 2025 |
FY 2025 |
| Depreciation, Depletion and Amortization |
$194,645,000 |
USD |
7.8% |
Q4 2025 |
Q1 2026 |
| Deferred Tax Assets, Net of Valuation Allowance |
$656,184,000 |
USD |
-3.8% |
Q3 2025 |
FY 2025 |
| Interest Expense |
$170,468,000 |
USD |
33% |
Q1 2024 |
Q2 2024 |